RMEI header logo


Online Activities


Experts in the Hot Seat: Navigating PCSK9 Inhibitor Prescribing in Persistent Elevated LDL-C 

In this activity, expert faculty will discuss barriers to the prescription of PCSK9Is and ways to overcome said barriers. The program will conclude with tools and resource recommendations that may be useful in facilitating access to this therapeutic option for the treatment of elevated LDL-C.


Navigating the Challenges of Prescribing PCSK9 Inhibitors in Patients with Persistent Elevated LDL-C 

James Underberg, MS, MD, FACPM, FACP, FASH, FASPC, FNLA; Mary Katherine Cheeley, PharmD, BCPS, CLS; and Winston Wong, PharmD, provide discussion of the obstacles to prescribing PCSK9Is and solutions for overcoming these barriers. The program will also provide tools and resources that will prove useful in facilitating access to this essential treatment option for patients with elevated LDL-C.